Pediatric cardiomyopathies over the last decade: a retrospective observational epidemiology study in a tertiary

Ola A Elmasry1, Terez B Kamel, Naglaa F El-Feki

  • 1Department of Pediatrics, Faculty of Medicine, Ain Shams University, Abbassia, Cairo, Egypt.

Insights

Pediatric cardiomyopathy (CM) in Egypt is a rare but serious condition. This study analyzed 124 cases over a decade, revealing key demographic and clinical features and emphasizing the need for a national registry.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Diseases
  • Genetics and Rare Diseases

Background:

  • Pediatric cardiomyopathy (CM) is a life-threatening heart disorder with unknown causes.
  • Limited data exists on childhood CM in Egypt due to the absence of a national registry.
  • This study aimed to characterize pediatric CM in Egypt.

Purpose of the Study:

  • To understand the demographic features of pediatric cardiomyopathy in Egypt.
  • To describe the clinical presentation of childhood CM.
  • To determine the frequency of different types of pediatric CM.

Main Methods:

  • Retrospective review of medical files of children diagnosed with CM.
  • Study period: 1997-2007.
  • Inclusion of 124 pediatric CM cases from 1876 cardiac patients at Ain Shams University.

Main Results:

  • Pediatric CM constituted 6.6% of cardiovascular cases seen at the clinic.
  • The study included 73 boys (58.9%) and 51 girls (41.1%) with a mean age of 3.82 years.
  • Parental consanguinity was noted in 19.4% of cases, and 6.5% had affected siblings.

Conclusions:

  • Scarcity of CM data in Egypt necessitates a national registry.
  • A registry would enable better assessment of the problem's scope and facilitate patient follow-up.
  • A national registry would also aid in screening family members of affected children.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...